{"id":51454,"date":"2026-02-22T17:23:51","date_gmt":"2026-02-22T17:23:51","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/aseptic-filling-machine-market-mordor\/"},"modified":"2026-10-30T15:31:44","modified_gmt":"2026-10-30T06:31:44","slug":"aseptic-filling-machine-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/aseptic-filling-machine-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ubb34\uade0 \ucda9\uc804\uae30 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2025\ub144 &#8211; 2030\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/aseptic-filling-machine-market-1754059979425-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/aseptic-filling-machine-market-size-image-1755588465605.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc0f mRNA \ubc31\uc2e0 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc885\uc591\ud559 \ubd84\uc57c\uc758 \uc989\uc2dc \ud22c\uc5ec \uac00\ub2a5\ud55c \ube44\uacbd\uad6c \uc81c\uc81c\ub85c\uc758 \uc804\ud658<\/li>\n<li class=\"toc-level-3\">4.2.3 \ucda9\uc804-\ub9c8\uac10 \uc5ed\ub7c9\uc744 \uc704\ud55c CDMO\uc5d0 \ub300\ud55c \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.4 Annex 1 (2023) \ubb34\uade0\uc131 \uac1c\uc815\uc73c\ub85c \uaddc\uc815 \uc900\uc218 \uac15\ud654<\/li>\n<li class=\"toc-level-3\">4.2.5 \ub85c\ubd07 \uc544\uc774\uc194\ub808\uc774\ud130 \ub77c\uc778\uc73c\ub85c \uc624\uc5fc \uc704\ud5d8 \uac10\uc18c<\/li>\n<li class=\"toc-level-3\">4.2.6 \ub9de\ucda4\ud615 \uc758\uc57d\ud488\uc5d0 \uc720\uc5f0\ud55c \uc18c\ub7c9 \ubc30\uce58 \ucda9\uc804\uae30 \ud544\uc694<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \uc544\uc774\uc194\ub808\uc774\ud130\/A\ub4f1\uae09 \ud074\ub9b0\ub8f8 CAPEX<\/li>\n<li class=\"toc-level-3\">4.3.2 \ubb34\uade0 \uc720\ud6a8\uc131 \uac80\uc0ac \ubc0f QA \ubd84\uc57c\uc758 \uc219\ub828 \uc778\ub825 \ubd80\uc871<\/li>\n<li class=\"toc-level-3\">4.3.3 \ubcf5\uc7a1\ud55c \ub2e4\uc911 \ud615\uc2dd \uc804\ud658\uc73c\ub85c \uc778\ud55c \uac00\ub3d9 \uc911\ub2e8 \uc2dc\uac04 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.3.4 \ucf5c\ub4dc\uccb4\uc778 \ub300\uccb4 \uae30\uc220 (LNP \uc2a4\ud504\ub808\uc774 \uac74\uc870)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58-USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uae30\uacc4 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ubc14\uc774\uc54c &amp; \uce74\ud2b8\ub9ac\uc9c0 \ucda9\uc804-\ub9c8\uac10 \ub77c\uc778<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc0ac\uc804 \ucda9\uc804 \uc8fc\uc0ac\uae30 (PFS) \ucda9\uc804\uae30<\/li>\n<li class=\"toc-level-3\">5.1.3 \ube14\ub85c\uc6b0-\ud544-\uc2e4 (BFS) \uc2dc\uc2a4\ud15c<\/li>\n<li class=\"toc-level-3\">5.1.4 IV \ubc31 \/ \ub300\uc6a9\ub7c9 \ube44\uacbd\uad6c \ucda9\uc804\uae30<\/li>\n<li class=\"toc-level-3\">5.1.5 \ub3d9\uacb0\uac74\uc870 \ud1b5\ud569 \ucda9\uc804\uae30<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uba78\uade0\/\ucc28\ub2e8 \uae30\uc220\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc544\uc774\uc194\ub808\uc774\ud130 \uae30\ubc18 \uc2dc\uc2a4\ud15c<\/li>\n<li class=\"toc-level-3\">5.2.2 RABS (\uc81c\ud55c \uc811\uadfc \uc7a5\ubcbd \uc2dc\uc2a4\ud15c)<\/li>\n<li class=\"toc-level-3\">5.2.3 \ubb34\uc7a5\uac11 \ub85c\ubd07 \uc544\uc774\uc194\ub808\uc774\ud130<\/li>\n<li class=\"toc-level-3\">5.2.4 \uae30\uc874 \ud074\ub9b0\ub8f8 \ub77c\uc778<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ucda9\uc804\ub7c9 \ubc94\uc704\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 1 mL \uc774\ud558 \ub9c8\uc774\ud06c\ub85c \ucda9\uc804<\/li>\n<li class=\"toc-level-3\">5.3.2 1 \u2013 20 mL \uc18c\ub7c9<\/li>\n<li class=\"toc-level-3\">5.3.3 20 \u2013 100 mL \uc911\uac04\ub7c9<\/li>\n<li class=\"toc-level-3\">5.3.4 100 mL \ucd08\uacfc \ub300\uc6a9\ub7c9 \ube44\uacbd\uad6c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ub300\ud615 \uc81c\uc57d \uc81c\uc870\uc5c5\uccb4<\/li>\n<li class=\"toc-level-3\">5.4.2 \uacc4\uc57d \uac1c\ubc1c &amp; \uc81c\uc870 \uc870\uc9c1 (CDMO)<\/li>\n<li class=\"toc-level-3\">5.4.3 \ubc31\uc2e0 \uc0dd\uc0b0\uc790<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc0dd\uba85\uacf5\ud559 &amp; \uc2a4\ud0c0\ud2b8\uc5c5<\/li>\n<li class=\"toc-level-3\">5.4.5 \ubcd1\uc6d0\/\uc870\uc81c \uc57d\uad6d<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uc218\uc900 \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Syntegon Technology<\/li>\n<li class=\"toc-level-3\">6.3.2 Bausch + Str\u00f6bel<\/li>\n<li class=\"toc-level-3\">6.3.3 IMA Group<\/li>\n<li class=\"toc-level-3\">6.3.4 Groninger<\/li>\n<li class=\"toc-level-3\">6.3.5 Optima Pharma<\/li>\n<li class=\"toc-level-3\">6.3.6 Rommelag (BFS)<\/li>\n<li class=\"toc-level-3\">6.3.7 Danaher Corporation<\/li>\n<li class=\"toc-level-3\">6.3.8 Stevanato Group (SGD)<\/li>\n<li class=\"toc-level-3\">6.3.9 Truking Feiyun<\/li>\n<li class=\"toc-level-3\">6.3.10 SKAN AG<\/li>\n<li class=\"toc-level-3\">6.3.11 Dara Pharma<\/li>\n<li class=\"toc-level-3\">6.3.12 Marchesini Group<\/li>\n<li class=\"toc-level-3\">6.3.13 Coesia (Flexlink-ITS)<\/li>\n<li class=\"toc-level-3\">6.3.14 Tetra Pak (\uc81c\uc57d \ucda9\uc804 \uc194\ub8e8\uc158)<\/li>\n<li class=\"toc-level-3\">6.3.15 Maquinaria Industria Mec\u00e1nica (MIM)<\/li>\n<li class=\"toc-level-3\">6.3.16 Steriline<\/li>\n<li class=\"toc-level-3\">6.3.17 Atec Pharmatechnik<\/li>\n<li class=\"toc-level-3\">6.3.18 Tofflon<\/li>\n<li class=\"toc-level-3\">6.3.19 Brevetti Angela<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ubb34\uade0 \ucda9\uc804\uae30 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21 (2025-2030)<\/p>\n<p>\uc2dc\uc7a5 \uac1c\uc694<\/p>\n<p>\ubb34\uade0 \ucda9\uc804\uae30 \uc2dc\uc7a5\uc740 2019\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc758 \uc870\uc0ac \uae30\uac04 \ub3d9\uc548 \uacac\uace0\ud55c \uc131\uc7a5\uc138\ub97c \ubcf4\uc77c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. 2025\ub144 0.77\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc600\ub358 \uc2dc\uc7a5\uc740 2030\ub144\uc5d0\ub294 1.03\uc5b5 \ub2ec\ub7ec\uc5d0 \ub3c4\ub2ec\ud558\uba70, \uc608\uce21 \uae30\uac04(2025-2030) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 6.07%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ubd81\ubbf8\uac00 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc73c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc73c\ub85c \ud3c9\uac00\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30<\/p>\n<p>\ubb34\uade0 \ucda9\uc804\uae30 \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc740 \uc5ec\ub7ec \ud575\uc2ec \ub3d9\uc778\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub418\uace0 \uc788\uc73c\uba70, \ub3d9\uc2dc\uc5d0 \uba87 \uac00\uc9c0 \uc81c\uc57d \uc694\uc778\uc5d0 \uc9c1\uba74\ud574 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc131\uc7a5 \ub3d9\ub825 (Drivers)<\/p>\n<p>*   \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc0f mRNA \ubc31\uc2e0 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5 (+1.8% CAGR \uc601\ud5a5): \ucc28\uc138\ub300 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc0f mRNA \ubc31\uc2e0 \uac1c\ubc1c\uc758 \uae09\uc99d\uc740 \ubb34\uade0 \ucda9\uc804\uae30 \uc2dc\uc7a5\uc758 \ud575\uc2ec \ub3d9\ub825\uc785\ub2c8\ub2e4. \ud2b9\ud788 Moderna\uc640 \uac19\uc740 \uae30\uc5c5\ub4e4\uc774 2025\ub144\uae4c\uc9c0 mRNA \uc0dd\uc0b0 \uc2dc\uc124\uc744 \uac00\ub3d9\ud560 \uacc4\ud68d\uc744 \uc138\uc6b0\uba74\uc11c, \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(LNP) \ud604\ud0c1\uc561\uc744 \uc704\ud55c \ud3d0\uc1c4\ud615 \ub85c\ubd07 \ucda9\uc804\uae30\uc758 \uc218\uc694\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc81c\uc81c\ub4e4\uc740 \uc5c4\uaca9\ud55c \uc628\ub3c4 \uad00\ub9ac\uac00 \ud544\uc694\ud558\uba70 \uc218\ub3d9 \uc811\ucd09\uc744 \ucd5c\uc18c\ud654\ud574\uc57c \ud558\ubbc0\ub85c, \uadf9\uc800\uc628 \ud638\ud658\uc131\uc744 \uac16\ucd98 \uc544\uc774\uc194\ub808\uc774\ud130 \uc791\uc5c5 \uc140\ub85c\uc758 \uc804\ud658\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c\ub294 \uc218\ub9cc \uac1c\uc758 \ubc14\uc774\uc54c\uc774 \uc544\ub2cc \uc218\ubc31 \uac1c\uc758 \ubc14\uc774\uc54c \ub2e8\uc704\ub85c \uce21\uc815\ub418\ub294 \ucd08\uc18c\ub7c9 \ubc30\uce58 \uc0dd\uc0b0\uc744 \uc694\uad6c\ud558\uba70, \uc774\ub294 \uc815\ubc00\ud558\uace0 \uc18c\ub7c9\uc5d0 \ud2b9\ud654\ub41c \uc194\ub8e8\uc158\uc5d0 \ub300\ud55c \uafb8\uc900\ud55c \ub2e4\ub144\uac04\uc758 \uc218\uc694\ub97c \ucc3d\ucd9c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc885\uc591\ud559 \ubd84\uc57c\uc758 \uc989\uc2dc \ud22c\uc5ec\ud615 \uc8fc\uc0ac\uc81c \uc804\ud658 (+1.2% CAGR \uc601\ud5a5): \uc554 \uce58\ub8cc \ubd84\uc57c\uc5d0\uc11c\ub294 \ud22c\uc5ec \uc624\ub958\ub97c \uc904\uc774\uace0 \uc900\ube44 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uae30 \uc704\ud574 \uc0ac\uc804 \ucda9\uc804 \ubc0f \uba78\uade0\ub41c \ud615\ud0dc\uc758 \uc758\uc57d\ud488\uc744 \uc120\ud638\ud558\ub294 \uacbd\ud5a5\uc774 \uac15\ud574\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC) \ubc0f \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c(Checkpoint Inhibitors)\uac00 \uc0ac\uc804 \ucda9\uc804 \uc8fc\uc0ac\uae30(PFS) \ubc0f \uce74\ud2b8\ub9ac\uc9c0 \ud615\ud0dc\ub85c \uc804\ud658\ub418\uba74\uc11c, \uc804\uc6a9 PFS \ub77c\uc778\uc758 \ucc98\ub9ac\ub7c9 \uc694\uad6c \uc0ac\ud56d\uc774 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uac15\ub825\ud55c \uc57d\ubb3c\uc744 \uc548\uc804\ud558\uac8c \ucc98\ub9ac\ud574\uc57c \ud558\ub294 \ud544\uc694\uc131\uc73c\ub85c \uc778\ud574 \uace0\ud574\uc0c1\ub3c4 \uc778\ub77c\uc778 \uac80\uc0ac \uae30\ub2a5\uc774 \uacb0\ud569\ub41c \uae00\ub7ec\ube0c\ub9ac\uc2a4 \uc544\uc774\uc194\ub808\uc774\ud130\uc5d0 \ub300\ud55c \ud22c\uc790\uac00 \ucd09\uc9c4\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   CDMO(\uc704\ud0c1\uac1c\ubc1c\uc0dd\uc0b0\uae30\uad00)\uc758 \ucda9\uc804-\uc644\uc81c \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00 (+1.5% CAGR \uc601\ud5a5): \uc81c\uc57d\uc0ac\ub4e4\uc740 \uc218\uc5b5 \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\ub294 \ucd08\uae30 \uc790\ubcf8 \ud22c\uc790\ub97c \ud53c\ud558\uace0 \uc804\ubb38 \uae30\uc220\uc744 \ud65c\uc6a9\ud558\uae30 \uc704\ud574 CDMO\uc640\uc758 \ud30c\ud2b8\ub108\uc2ed\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\uc5d0 \ub530\ub77c CDMO\ub294 \uc8fc\uc0ac\uae30, \ubc14\uc774\uc54c, \uce74\ud2b8\ub9ac\uc9c0 \ub4f1 \ub2e4\uc591\ud55c \ud3ec\ub9f7 \uac04\uc5d0 \uba87 \uc2dc\uac04 \ub0b4\uc5d0 \uc804\ud658 \uac00\ub2a5\ud55c \ub2e4\uc911 \ud3ec\ub9f7 \ub85c\ubd07 \uc2dc\uc2a4\ud15c\uc73c\ub85c \uc5c5\uadf8\ub808\uc774\ub4dc\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc544\uc6c3\uc18c\uc2f1 \ucd94\uc138\ub294 \uac1c\ubcc4 \uc81c\uc57d\uc0ac\uc758 \ud30c\uc774\ud504\ub77c\uc778 \ubcc0\ub3d9\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \uc7a5\ube44 \uc8fc\ubb38\uc744 \uafb8\uc900\ud788 \uc720\uc9c0\uc2dc\ud0a4\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<br \/>\n*   Annex 1 \uba78\uade0 \uaddc\uc815 \uac15\ud654 (+0.9% CAGR \uc601\ud5a5): 2023\ub144 \uc720\ub7fd\uc758 Annex 1 \uac1c\uc815\uc548\uc740 \uc704\ud5d8 \uae30\ubc18 \uba78\uade0 \uaddc\uc815\uc744 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ud655\ub300\ud558\uc5ec, \uc0ac\uc2e4\uc0c1 \uc2e0\uaddc \uc2dc\uc124\uc5d0 \uc7a5\ubcbd \uae30\uc220(Barrier Technology)\uc744 \uc758\ubb34\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uae30\uc874 RABS(Restricted Access Barrier Systems) \ubc0f \uc7ac\ub798\uc2dd \ud074\ub9b0\ub8f8\uc758 \uac1c\uc870 \ub610\ub294 \uc804\uba74 \uad50\uccb4\ub97c \uc720\ub3c4\ud558\uba70, \uc790\ub3d9\ud654\ub41c \uc624\uc5fc \uc81c\uac70 \uc8fc\uae30\ub97c \uac16\ucd98 \uc544\uc774\uc194\ub808\uc774\ud130 \ud50c\ub7ab\ud3fc\uc73c\ub85c\uc758 \uc870\ub2ec\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ub85c\ubd07 \uc544\uc774\uc194\ub808\uc774\ud130 \ub77c\uc778\uc744 \ud1b5\ud55c \uc624\uc5fc \uc704\ud5d8 \uac10\uc18c (+0.7% CAGR \uc601\ud5a5): \uc778\uac04\uc758 \uac1c\uc785\uc744 \uac70\uc758 \uc81c\ub85c\uc5d0 \uac00\uae5d\uac8c \uc904\uc774\ub294 \ub85c\ubd07 \uc544\uc774\uc194\ub808\uc774\ud130 \ub77c\uc778\uc740 \uc624\uc5fc \uc704\ud5d8\uc744 \ucd5c\uc18c\ud654\ud558\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uac1c\uc778 \ub9de\ucda4\ud615 \uc758\uc57d\ud488\uc744 \uc704\ud55c \uc720\uc5f0\ud55c \uc18c\ub7c9 \ubc30\uce58 \ucda9\uc804\uae30 \ud544\uc694\uc131 (+0.6% CAGR \uc601\ud5a5): \uac1c\uc778 \ub9de\ucda4\ud615 \uc758\uc57d\ud488\uc758 \ubd80\uc0c1\uc740 \uc18c\ub7c9 \ubc30\uce58 \uc0dd\uc0b0\uc5d0 \uc720\uc5f0\ud558\uac8c \ub300\uc751\ud560 \uc218 \uc788\ub294 \ucda9\uc804\uae30 \uc218\uc694\ub97c \uc99d\uac00\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc81c\uc57d \uc694\uc778 (Restraints)<\/p>\n<p>*   \ub192\uc740 \uc544\uc774\uc194\ub808\uc774\ud130\/Grade A \ud074\ub9b0\ub8f8 \ucd08\uae30 \ud22c\uc790 \ube44\uc6a9 (-1.3% CAGR \uc601\ud5a5): \uc0c8\ub85c\uc6b4 \uc544\uc774\uc194\ub808\uc774\ud130 \ub77c\uc778\uc740 \uc77c\ubc18\uc801\uc73c\ub85c 1,000\ub9cc~1,500\ub9cc \ub2ec\ub7ec\uc758 \ube44\uc6a9\uc774 \ub4e4\uace0 \uad11\ubc94\uc704\ud55c \uac74\ubb3c \uac1c\uc870\uac00 \ud544\uc694\ud558\uc5ec, \ub9ce\uc740 \ucd08\uae30 \ub2e8\uacc4 \ubc14\uc774\uc624\ud14d \uae30\uc5c5\uc5d0\uac8c\ub294 \uc0c1\ub2f9\ud55c \uc7ac\uc815\uc801 \uc7a5\ubcbd\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \uc124\uce58 \ud6c4\uc5d0\ub3c4 \uc5f0\uac04 \uac80\uc99d \ubc0f \uc720\uc9c0\ubcf4\uc218 \ube44\uc6a9\uc774 \uc0c1\ub2f9\ud55c \uc6b4\uc601 \uc608\uc0b0\uc744 \uc18c\ubaa8\ud569\ub2c8\ub2e4.<br \/>\n*   \ubb34\uade0 \uac80\uc99d \ubc0f \ud488\uc9c8 \ubcf4\uc99d(QA) \ubd84\uc57c\uc758 \uc219\ub828\ub41c \uc778\ub825 \ubd80\uc871 (-0.8% CAGR \uc601\ud5a5): \uc81c\uc870\uc5c5\uccb4 5\uacf3 \uc911 4\uacf3\uc774 \uc790\ub3d9\ud654 \ubc0f \uba78\uade0 \ubcf4\uc99d \ub178\ud558\uc6b0 \ubd80\uc871\uc744 \ubcf4\uace0\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \ud504\ub85c\uc81d\ud2b8 \uc77c\uc815\uc744 \uc9c0\uc5f0\uc2dc\ud0a4\uace0 \ud76c\uc18c\ud55c \uc778\ub825\uc758 \uc784\uae08 \uc778\ud50c\ub808\uc774\uc158\uc744 \uc720\ubc1c\ud569\ub2c8\ub2e4. \ub85c\ubd07 \ubc0f \ub370\uc774\ud130 \uae30\ubc18 \uc2dc\uc2a4\ud15c\uc774 \ud655\uc0b0\ub418\uba74\uc11c \uc18c\ud504\ud2b8\uc6e8\uc5b4, \ubd84\uc11d, \uc804\ud1b5\uc801\uc778 \ubbf8\uc0dd\ubb3c\ud559\uc5d0 \uac78\uce5c \uc804\ubb38\uc131\uc774 \uc694\uad6c\ub418\uc9c0\ub9cc, \uad50\uc721 \uc2dc\uc2a4\ud15c\uc774 \uc774\ub97c \ub530\ub77c\uac00\uc9c0 \ubabb\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubcf5\uc7a1\ud55c \ub2e4\uc911 \ud3ec\ub9f7 \uc804\ud658\uc73c\ub85c \uc778\ud55c \uac00\ub3d9 \uc911\ub2e8 \uc2dc\uac04 (-0.6% CAGR \uc601\ud5a5): \uc5ec\ub7ec \uc81c\ud488\uc744 \uc0dd\uc0b0\ud558\ub294 \uc2dc\uc124\uc5d0\uc11c\ub294 \ubcf5\uc7a1\ud55c \ub2e4\uc911 \ud3ec\ub9f7 \uc804\ud658\uc774 \uc0dd\uc0b0 \uac00\ub3d9 \uc911\ub2e8 \uc2dc\uac04\uc744 \uc720\ubc1c\ud558\uc5ec \ud6a8\uc728\uc131\uc744 \uc800\ud574\ud569\ub2c8\ub2e4.<br \/>\n*   \ucf5c\ub4dc\uccb4\uc778 \ub300\uccb4 \uae30\uc220\uc758 \ubd80\uc0c1 (-0.4% CAGR \uc601\ud5a5): \uc7a5\uae30\uc801\uc73c\ub85c \ucf5c\ub4dc\uccb4\uc778\uc5d0 \ub300\ud55c \uc758\uc874\ub3c4\ub97c \uc904\uc774\ub294 \ub300\uccb4 \uae30\uc220\uc758 \ubc1c\uc804\uc740 \ubb34\uade0 \ucda9\uc804\uae30 \uc2dc\uc7a5\uc5d0 \uc601\ud5a5\uc744 \ubbf8\uce60 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>*   \uae30\uacc4 \uc720\ud615\ubcc4:<br \/>\n    *   \uc0ac\uc804 \ucda9\uc804 \uc8fc\uc0ac\uae30(Pre-filled Syringe) \ucda9\uc804\uae30: 2024\ub144 \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 39.57%\ub97c \ucc28\uc9c0\ud558\uba70 \uc9c0\ubc30\uc801\uc778 \uc704\uce58\ub97c \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ud22c\uc5ec \uc624\ub958\ub97c \uc904\uc774\uace0 \ud22c\uc5ec \uc18d\ub3c4\ub97c \ub192\uc774\ub294 \uc989\uc2dc \ud22c\uc5ec\ud615 \uce58\ub8cc\uc81c\ub85c\uc758 \uc804\ud658\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. Syntegon\uc758 MLD Advanced \ud50c\ub7ab\ud3fc\uacfc \uac19\uc774 \ubd84\ub2f9 400\uac1c \ub2e8\uc704\ub97c \ucc98\ub9ac\ud560 \uc218 \uc788\ub294 \uc7a5\ube44\uc758 \ub3c4\uc785\uc740 \uc774\ub7ec\ud55c \ub9ac\ub354\uc2ed\uc744 \ub354\uc6b1 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \ube14\ub85c\uc6b0-\ud544-\uc2e4(Blow-Fill-Seal, BFS) \uc7a5\ube44: 2030\ub144\uae4c\uc9c0 10.38%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. BFS\ub294 \uc6d0\uc2a4\ud15d \uc6a9\uae30 \uc131\ud615 \ubc0f \ucda9\uc804 \uacf5\uc815\uc744 \ud1b5\ud574 \uc624\uc5fc \uc704\ud5d8\uacfc \uc6a9\ub7c9\ub2f9 \ube44\uc6a9\uc744 \ub0ae\ucd9c \uc218 \uc788\uc5b4, \ub300\ub7c9 \uc0dd\uc0b0\ub418\ub294 \uc81c\ub124\ub9ad \uc758\uc57d\ud488 \ubc0f \ubc31\uc2e0 \uc0dd\uc0b0\uc790\uc5d0\uac8c \uc911\uc694\ud55c \uc694\uc18c\uc785\ub2c8\ub2e4.<br \/>\n    *   \ubc14\uc774\uc54c \ubc0f \uce74\ud2b8\ub9ac\uc9c0 \uc7a5\ube44: \ud2b9\ud788 \uc784\uc0c1 \uc2dc\ud5d8 \uacf5\uae09 \ubd84\uc57c\uc5d0\uc11c \ud3ec\ub9f7 \uc720\uc5f0\uc131\uc774 \ub300\ub7c9 \uc0dd\uc0b0 \ud6a8\uc728\uc131\ubcf4\ub2e4 \uc911\uc694\ud558\uac8c \uc791\uc6a9\ud558\uc5ec \uacac\uace0\ud55c \uc218\uc694\ub97c \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub3d9\uacb0\uac74\uc870 \ud1b5\ud569 \ucda9\uc804\uae30\ub294 \ub3d9\uacb0\uac74\uc870 \uc548\uc815\uc131\uc774 \ud544\uc694\ud55c \uc81c\ud488\uc5d0\uc11c \ud2c8\uc0c8\uc2dc\uc7a5\uc744 \ud615\uc131\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uba78\uade0 \uae30\uc220\ubcc4:<br \/>\n    *   \uc544\uc774\uc194\ub808\uc774\ud130 \uae30\ubc18 \uc2dc\uc2a4\ud15c: 2024\ub144 \uc9c0\ucd9c\uc758 46.59%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud588\uc2b5\ub2c8\ub2e4. \uaddc\uc81c \ub2f9\uad6d\uc774 \uc911\uc694 \uad6c\uc5ed\uc5d0\uc11c Grade A \uc870\uac74\uc744 \ubcf4\uc7a5\ud558\ub294 \ud3d0\uc1c4\ud615 \uc7a5\ubcbd\uc744 \uc120\ud638\ud558\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \uac15\ub825\ud55c \uc624\uc5fc \uc81c\uac70 \uc8fc\uae30 \ubc0f \ud1b5\ud569 \uc785\uc790 \ubaa8\ub2c8\ud130\ub9c1\uc740 Annex 1\uc758 \uc5c4\uaca9\ud55c \ubb38\uc11c\ud654 \uc694\uad6c \uc0ac\ud56d\uc744 \ucda9\uc871\ud569\ub2c8\ub2e4.<br \/>\n    *   \uae00\ub7ec\ube0c\ub9ac\uc2a4 \ub85c\ubd07 \uc544\uc774\uc194\ub808\uc774\ud130: 2030\ub144\uae4c\uc9c0 10.47%\uc758 CAGR\ub85c \uc131\uc7a5\ud558\uba70, \uc81c\uc870\uc5c5\uccb4\ub4e4\uc774 \uc81c\ub85c \ud130\uce58 \uc0dd\uc0b0\uc744 \ucd94\uad6c\ud568\uc5d0 \ub530\ub77c \ube60\ub974\uac8c \ud655\uc0b0\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ucda9\uc804\ub7c9 \ubc94\uc704\ubcc4:<br \/>\n    *   1-20 mL: 2024\ub144 \ubb34\uade0 \ucda9\uc804\uae30 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 43.26%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ub2e8\uc77c\ud074\ub860\ud56d\uccb4, \uc778\uc290\ub9b0 \ubc0f \uc774 \ubc94\uc704\uc5d0 \uc18d\ud558\ub294 \ud2b9\uc218 \uc8fc\uc0ac\uc81c\uc758 \ubcf4\ud3b8\uc131\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4.<br \/>\n    *   \u22641 mL (\ub9c8\uc774\ud06c\ub85c \ud544): 2030\ub144\uae4c\uc9c0 9.17%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc720\uc804\uc790 \ud3b8\uc9d1 \ubca1\ud130 \ubc0f \ud658\uc790\ub2f9 \uc218\uc2ed \ub9c8\uc774\ud06c\ub85c\ub9ac\ud130\ub9cc \ud544\uc694\ud55c \uc790\uac00 \uc138\ud3ec \uce58\ub8cc\uc81c\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub429\ub2c8\ub2e4. \u00b11%\uae4c\uc9c0\uc758 \uc815\ud655\ud55c \ubd84\uc8fc\uac00 \ud544\uc218\uc801\uc774\ubbc0\ub85c, \uace0\ud574\uc0c1\ub3c4 \uc5f0\ub3d9 \ud38c\ud504 \ubc0f \uc778\ub77c\uc778 \uc911\ub7c9 \uac80\uc0ac \uc54c\uace0\ub9ac\uc998 \ucc44\ud0dd\uc774 \uc694\uad6c\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4:<br \/>\n    *   CDMO: 2024\ub144 \uc7a5\ube44 \uc9c0\ucd9c\uc758 34.72%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4. \ube0c\ub79c\ub4dc \uc758\uc57d\ud488 \uc2a4\ud3f0\uc11c\ub4e4\uc774 \uc790\uc0b0 \uacbd\ub7c9\ud654 \ubaa8\ub378\uc744 \ucd94\uad6c\ud558\uba74\uc11c\ub3c4 \uac80\uc99d\ub41c \uc0dd\uc0b0 \ub2a5\ub825\uc5d0 \uc2e0\uc18d\ud558\uac8c \uc811\uadfc\ud558\ub824\ub294 \uacbd\ud5a5\uc774 \ubc18\uc601\ub41c \uacb0\uacfc\uc785\ub2c8\ub2e4.<br \/>\n    *   \ubc31\uc2e0 \uc0dd\uc0b0\uc790: \uc815\ubd80\uc758 \ud32c\ub370\ubbf9 \ub300\ube44 \ubc0f \uc815\uae30 \uc608\ubc29 \uc811\uc885 \ucd94\uc9c4\uc73c\ub85c \uc778\ud574 2030\ub144\uae4c\uc9c0 9.75%\uc758 \uac00\uc7a5 \uac00\ud30c\ub978 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2024\ub144 \ub9e4\ucd9c\uc758 37.33%\ub97c \ucc28\uc9c0\ud558\uba70 \ucd5c\ub300 \uc2dc\uc7a5\uc73c\ub85c \uc790\ub9ac\ub9e4\uae40\ud588\uc2b5\ub2c8\ub2e4. Novo Nordisk\uc758 41\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8 \ud074\ub808\uc774\ud134 \uacf5\uc7a5 \uac74\uc124 \ubc0f Eli Lilly\uc758 \ucca8\ub2e8 \uc8fc\uc0ac\uc81c \ub77c\uc778 \ud22c\uc790\uac00 \uc774\ub97c \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4. \uac15\ub825\ud55c FDA \uac10\ub3c5\uacfc \uc219\ub828\ub41c \uc5d4\uc9c0\ub2c8\uc5b4\uc5d0 \ub300\ud55c \uc811\uadfc\uc131\uc740 \uc784\uae08 \uc778\uc0c1\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \uad6d\ub0b4 \uc81c\uc870\ub97c \uc7a5\ub824\ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \ub450 \ubc88\uc9f8\ub85c \ud070 \uae30\uc5ec \uc9c0\uc5ed\uc73c\ub85c, Annex 1\uc758 \uaddc\uc81c \uba85\ud655\uc131\uacfc \ub3c5\uc77c\uc758 \ucda9\uc804-\uc644\uc81c \ud5c8\ube0c \ubd80\uc0c1\uc5d0 \ud798\uc785\uc5b4 \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Sanofi, Boehringer Ingelheim, Stevanato\uc640 \uac19\uc740 \uae30\uc5c5\ub4e4\uc758 \ud22c\uc790\uac00 \ud604\uc9c0 \uc7a5\ube44 \uc218\uc694\ub97c \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2030\ub144\uae4c\uc9c0 8.36%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc911\uad6d\uc758 \ubc14\uc774\uc624 \uc81c\uc57d \ubd80\uc591\ucc45\uacfc \uc778\ub3c4\uc758 \uc0dd\uc0b0 \uc5f0\uacc4 \uc778\uc13c\ud2f0\ube0c\uac00 \uc544\uc774\uc194\ub808\uc774\ud130 \uae30\ubc18\uc758 \uc2e0\uaddc \uc2dc\uc124 \uac74\uc124\uc744 \ucd09\ubc1c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud604\uc9c0 CDMO\ub4e4\uc740 \ub2e4\uad6d\uc801 \ud504\ub85c\uc81d\ud2b8\ub97c \uc218\uc8fc\ud558\uae30 \uc704\ud574 \uc11c\uad6c \ub85c\ubd07 \uae30\uc220\uc744 \ub3c4\uc785\ud558\uba74\uc11c\ub3c4 \uacbd\uc7c1\ub825 \uc788\ub294 \uac00\uaca9\uc744 \uc81c\uc2dc\ud558\uba70 \ud45c\uc900\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uacfc \ud55c\uad6d\uc740 \ud488\uc9c8 \uba85\uc131\uc744 \ubcf4\ud638\ud558\uae30 \uc704\ud574 \uc815\ubc00 \uc790\ub3d9\ud654\uc5d0 \ud22c\uc790\ud558\uace0 \uc788\uc73c\uba70, \ud638\uc8fc\ub294 \ub3d9\ub0a8\uc544\uc2dc\uc544\uc5d0 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud558\ub294 mRNA \ud5c8\ube0c\ub85c \uc790\ub9ac\ub9e4\uae40\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\ubb34\uade0 \ucda9\uc804\uae30 \uc0b0\uc5c5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \ud1b5\ud569\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. Syntegon, IMA, Rommelag\uacfc \uac19\uc740 \uc2dc\uc7a5 \uc120\ub450 \uae30\uc5c5\ub4e4\uc740 \uc218\uc2ed \ub144\uac04 \ucd95\uc801\ub41c \uac80\uc99d \ub77c\uc774\ube0c\ub7ec\ub9ac\uc640 \ub2e4\uc218\uc758 \uc11c\ube44\uc2a4 \uc13c\ud130\ub97c \ud65c\uc6a9\ud558\uc5ec \uc124\uce58 \ud6c4 \uac00\ub3d9 \uc2dc\uac04\uc744 \ubcf4\uc7a5\ud558\uba70 \uace0\uac1d\uc744 \ud655\ubcf4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Syntegon\uc740 2024\ub144 \uc8fc\ubb38\ub7c9 11% \uc99d\uac00\uc640 \ubaa9\ud45c \uc778\uc218\ud569\ubcd1\uc744 \ud1b5\ud55c \ub85c\ubd07 \uc81c\ud488\uad70 \ud655\uc7a5\uc744 \ud1b5\ud574 \uaddc\ubaa8\uc640 \uc804\ubb38\uc131\uc774 \uc2dc\uc7a5 \uc9c0\ubc30\ub825\uc744 \uac15\ud654\ud558\ub294 \ubc29\uc2dd\uc744 \ubcf4\uc5ec\uc8fc\uc5c8\uc2b5\ub2c8\ub2e4. Novo Holdings\uc758 110\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8 Catalent \uc778\uc218\ub294 \uc678\ubd80 \uc790\ubcf8\uc774 \uc774 \ubd84\uc57c\uc758 \uc131\uc7a5 \uc7a0\uc7ac\ub825\uc5d0 \ub300\ud574 \ub192\uc740 \uc2e0\ub8b0\ub97c \uac00\uc9c0\uace0 \uc788\uc74c\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<\/p>\n<p>\ud604\uc7ac \uc2dc\uc7a5 \ucc28\ubcc4\ud654\ub294 \ub514\uc9c0\ud138 \ud2b8\uc708, \uc608\uce21 \uc720\uc9c0\ubcf4\uc218, \uc124\uce58 \uae30\uac04\uc744 \ub2e8\ucd95\ud558\ub294 \ubaa8\ub4c8\ud615 \uc124\uacc4\uc5d0 \uc911\uc810\uc744 \ub450\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2e0\ud765 \uacbd\uc7c1\uc5c5\uccb4\ub4e4\uc740 \uc138\ud3ec \uce58\ub8cc\uc81c \ub9c8\uc774\ud06c\ub85c \ubc30\uce58 \ub77c\uc778 \ubc0f \ubd84\uc0b0\ud615 \uc0dd\uc0b0 \uce74\ud2b8\uc5d0 \uc9d1\uc911\ud558\uc5ec \ud2c8\uc0c8\uc2dc\uc7a5\uc744 \uac1c\ucc99\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc9c0\uc5ed\uc801 \ud655\uc7a5\ub3c4 \uacc4\uc18d\ub418\uace0 \uc788\uc73c\uba70, \uc720\ub7fd \uae30\uc5c5\ub4e4\uc740 \ubbf8\uad6d\uc5d0 \ub370\ubaa8 \ub7a9\uc744 \uac1c\uc124\ud558\uace0 \uc544\uc2dc\uc544 \uae30\uc5c5\ub4e4\uc740 \uc11c\uad6c IP\ub97c \ub77c\uc774\uc120\uc2a4\ud558\uc5ec \uad6d\ub0b4 \uc218\uc694\ub97c \ucda9\uc871\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uace0\uac1d \ucda9\uc131\ub3c4\ub294 \uc7a5\uae30\uc801\uc778 \ub77c\uc774\ud504\uc0ac\uc774\ud074 \uc9c0\uc6d0\uc774 \uac00\ub2a5\ud55c \uacf5\uae09\uc5c5\uccb4\uc5d0 \uc9d1\uc911\ub418\ub294 \uacbd\ud5a5\uc774 \uc788\uc5b4, \uc11c\ube44\uc2a4 \ud488\uc9c8\uc774 \uae30\uacc4\uc801 \ud601\uc2e0\ub9cc\ud07c \uc911\uc694\ud55c \uacbd\uc7c1 \ubd84\uc57c\ub85c \uc790\ub9ac \uc7a1\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc0b0\uc5c5 \ub9ac\ub354: Syntegon Technology, Bausch + Str\u00f6bel, IMA Group, Groninger, Optima Pharma.<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5:<br \/>\n*   2025\ub144 5\uc6d4: Syntegon\uc740 \uc815\ubc00 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ucda9\uc804\uc744 \uc704\ud55c \ucca8\ub2e8 \uc561\uccb4 \ucc98\ub9ac \ubaa8\ub4c8\uc744 \ud1b5\ud569\ud55c Pharmatag 2025 \ub77c\uc778\uc744 \ucd9c\uc2dc\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 4\uc6d4: Syntegon\uc740 \ud5a5\uc0c1\ub41c \uc778\ub77c\uc778 \uc81c\uc5b4 \uae30\ub2a5\uc744 \ud1b5\ud574 \ubd84\ub2f9 400\uac1c \ub2e8\uc704\ub97c \ucc98\ub9ac\ud558\ub294 MLD Advanced RTU \uc8fc\uc0ac\uae30 \ucda9\uc804\uae30\ub97c \ucd9c\uc2dc\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 5\uc6d4: Stevanato Group\uc740 EZ-fill \uc8fc\uc0ac\uae30 \uc0dd\uc0b0\ub7c9 \ud655\ub300\ub97c \uc704\ud574 Cisterna di Latina \uc2dc\uc124\uc744 \uac1c\uc124\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 3\uc6d4: Argonaut Manufacturing Services\ub294 \uce98\ub9ac\ud3ec\ub2c8\uc544\uc5d0 \uc544\uc774\uc194\ub808\uc774\ud130 \uae30\ubc18 \uc8fc\uc0ac\uae30 \ubc0f \uce74\ud2b8\ub9ac\uc9c0 \uc0dd\uc0b0 \ub2a5\ub825 \ud655\ub300\ub97c \uc704\ud574 4,500\ub9cc \ub2ec\ub7ec\ub97c \ud22c\uc790\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \ubb34\uade0 \ucda9\uc804 \uae30\uacc4 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud558\uba70, \uc2dc\uc7a5\uc758 \uc815\uc758, \ubc94\uc704, \uc5f0\uad6c \ubc29\ubc95\ub860 \ubc0f \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5\uc744 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc131\uc7a5 \uc804\ub9dd:<br \/>\n2025\ub144 \ubb34\uade0 \ucda9\uc804 \uae30\uacc4 \uc2dc\uc7a5 \uaddc\ubaa8\ub294 0.77\uc5b5 \ub2ec\ub7ec\uc5d0 \ub2ec\ud588\uc73c\uba70, 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 6.07%\ub85c \uafb8\uc900\ud788 \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\uc778:<br \/>\n\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uc774\ub044\ub294 \ud575\uc2ec \uc694\uc778\uc73c\ub85c\ub294 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc0f mRNA \ubc31\uc2e0 \ud30c\uc774\ud504\ub77c\uc778\uc758 \uc9c0\uc18d\uc801\uc778 \ud655\uc7a5, \uc885\uc591\ud559 \ubd84\uc57c\uc5d0\uc11c \uc989\uc2dc \ud22c\uc5ec \uac00\ub2a5\ud55c \uc8fc\uc0ac\uc81c(Ready-To-Administer Parenterals)\ub85c\uc758 \uc804\ud658 \uac00\uc18d\ud654, \uc704\ud0c1\uac1c\ubc1c\uc0dd\uc0b0(CDMO) \uae30\uc5c5\uc73c\ub85c\uc758 \ucda9\uc804-\ub9c8\uac10(Fill-Finish) \uacf5\uc815 \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00, Annex 1 (2023) \ubb34\uade0\uc131 \uac1c\uc815\uc73c\ub85c \uc778\ud55c \uaddc\uc81c \uc900\uc218 \uac15\ud654, \ub85c\ubd07 \uc544\uc774\uc194\ub808\uc774\ud130 \ub77c\uc778\uc744 \ud1b5\ud55c \uc624\uc5fc \uc704\ud5d8 \uac10\uc18c, \uadf8\ub9ac\uace0 \ub9de\ucda4\ud615 \uc758\uc57d\ud488 \uc0dd\uc0b0\uc744 \uc704\ud55c \uc720\uc5f0\ud558\uace0 \uc18c\ub7c9 \ubc30\uce58 \ucda9\uc804 \uc2dc\uc2a4\ud15c\uc758 \ud544\uc694\uc131 \uc99d\ub300 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<br \/>\n\ubc18\uba74, \ub192\uc740 \uc544\uc774\uc194\ub808\uc774\ud130 \ubc0f Grade A \ud074\ub9b0\ub8f8 \uad6c\ucd95\uc744 \uc704\ud55c \ucd08\uae30 \ud22c\uc790 \ube44\uc6a9(Capex), \ubb34\uade0 \uac80\uc99d \ubc0f \ud488\uc9c8 \ubcf4\uc99d \ubd84\uc57c\uc758 \uc219\ub828\ub41c \uc778\ub825 \ubd80\uc871, \ubcf5\uc7a1\ud55c \ub2e4\uc911 \ud3ec\ub9f7 \uc804\ud658\uc73c\ub85c \uc778\ud55c \uc0dd\uc0b0 \uac00\ub3d9 \uc911\ub2e8 \uc2dc\uac04 \uc99d\uac00, \uadf8\ub9ac\uace0 \ucf5c\ub4dc\uccb4\uc778 \ub300\uccb4 \uae30\uc220(\uc608: LNP \uc2a4\ud504\ub808\uc774 \uac74\uc870)\uc758 \ubc1c\uc804\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc138\ubd84\ud654 \ubc0f \ud2b8\ub80c\ub4dc:<br \/>\n*   \uae30\uacc4 \uc720\ud615\ubcc4: 2024\ub144 \ub9e4\ucd9c\uc758 39.57%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud558\ub294 \uac83\uc740 \uc0ac\uc804 \ucda9\uc804 \uc8fc\uc0ac\uae30(PFS) \ucda9\uc804\uae30\uc785\ub2c8\ub2e4. \uc774\ub294 \uc989\uc2dc \uc8fc\uc0ac \uac00\ub2a5\ud55c \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \uc218\uc694 \uc99d\uac00\uc5d0 \ud06c\uac8c \uae30\uc778\ud569\ub2c8\ub2e4. \uc774 \uc678\uc5d0\ub3c4 \ubc14\uc774\uc54c \ubc0f \uce74\ud2b8\ub9ac\uc9c0 \ucda9\uc804-\ub9c8\uac10 \ub77c\uc778, \ube14\ub85c\uc6b0-\ud544-\uc2e4(BFS) \uc2dc\uc2a4\ud15c, IV \ubc31\/\ub300\uc6a9\ub7c9 \uc8fc\uc0ac\uc81c \ucda9\uc804\uae30, \ub3d9\uacb0\uac74\uc870 \ud1b5\ud569 \ucda9\uc804\uae30 \ub4f1\uc774 \ubd84\uc11d\ub429\ub2c8\ub2e4.<br \/>\n*   \uc0b4\uade0\/\ucc28\ub2e8 \uae30\uc220\ubcc4: \uc9c1\uc811\uc801\uc778 \uc778\uccb4 \uc811\ucd09\uc744 \uc5c6\uc560\uace0 \uc624\uc5fc \uc704\ud5d8\uc744 \ud604\uc800\ud788 \uc904\uc774\ub294 \uae00\ub7ec\ube0c\ub9ac\uc2a4 \ub85c\ubd07 \uc544\uc774\uc194\ub808\uc774\ud130 \uc2dc\uc2a4\ud15c\uc774 10.47%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uae30\uc220 \ud2b8\ub80c\ub4dc\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\uc774\uc194\ub808\uc774\ud130 \uae30\ubc18 \uc2dc\uc2a4\ud15c, RABS(Restricted Access Barrier System), \uae30\uc874 \ud074\ub9b0\ub8f8 \ub77c\uc778 \ub4f1\ub3c4 \ud3ec\ud568\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: CDMO\ub294 2024\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 34.72%\ub97c \uae30\ub85d\ud558\uba70 \ubb34\uade0 \ucda9\uc804 \uae30\uacc4\uc758 \uc911\uc694\ud55c \uad6c\ub9e4\uc790\ub85c \uc790\ub9ac\ub9e4\uae40\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc81c\uc57d\uc0ac\ub4e4\uc774 \ub300\uaddc\ubaa8 \uc790\ubcf8 \uc9c0\ucd9c\uc744 \ud53c\ud558\uace0 \uc804\ubb38\uc801\uc778 \ucda9\uc804-\ub9c8\uac10 \uc5ed\ub7c9\uc744 \ud65c\uc6a9\ud558\uae30 \uc704\ud574 \uc544\uc6c3\uc18c\uc2f1\uc744 \uc120\ud638\ud558\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \ube45\ud30c\ub9c8 \uc81c\uc870\uc0ac, \ubc31\uc2e0 \uc0dd\uc0b0\uc790, \uc0dd\uba85\uacf5\ud559 \ubc0f \uc2a4\ud0c0\ud2b8\uc5c5, \ubcd1\uc6d0\/\uc870\uc81c \uc57d\uad6d \ub4f1\ub3c4 \uc8fc\uc694 \ucd5c\uc885 \uc0ac\uc6a9\uc790\uc785\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2030\ub144\uae4c\uc9c0 8.36%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ubd81\ubbf8, \uc720\ub7fd, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8 \uc9c0\uc5ed\ub3c4 \uc0c1\uc138\ud788 \ubd84\uc11d\ub429\ub2c8\ub2e4.<br \/>\n*   \ucda9\uc804\ub7c9 \ubc94\uc704\ubcc4: 1mL \uc774\ud558\uc758 \ub9c8\uc774\ud06c\ub85c \ucda9\uc804\ubd80\ud130 100mL \uc774\uc0c1\uc758 \ub300\uc6a9\ub7c9 \uc8fc\uc0ac\uc81c\uae4c\uc9c0 \ub2e4\uc591\ud55c \ucda9\uc804\ub7c9 \ubc94\uc704\uc5d0 \ub530\ub978 \uc2dc\uc7a5 \ubd84\uc11d\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd:<br \/>\n\ubcf4\uace0\uc11c\ub294 Syntegon Technology, Bausch + Str\u00f6bel, IMA Group, Groninger, Optima Pharma, Rommelag, Danaher Corporation, Stevanato Group \ub4f1 \uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc758 \ud504\ub85c\ud544, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d \ubc0f \ucd5c\uadfc \uac1c\ubc1c \ub3d9\ud5a5\uc744 \uc0c1\uc138\ud788 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd:<br \/>\n\ubbf8\ucda9\uc871 \uc218\uc694 \ud3c9\uac00\ub97c \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uc7a0\uc7ac\uc801 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd\uc744 \uc81c\uc2dc\ud558\uba70, \ud5a5\ud6c4 \uc2dc\uc7a5 \ubc1c\uc804 \ubc29\ud5a5\uc5d0 \ub300\ud55c \ud1b5\ucc30\ub825\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-51454","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/51454"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=51454"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/51454\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=51454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=51454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=51454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}